Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Asymchem Laboratories Tianjin (002821 CH)
Watchlist
101
Analysis
Health Care
•
China
Asymchem Laboratories (Tianjin) Co., Ltd. operates as a pharmaceutical company. The Company researches, produces, and sells organic and inorganic chemicals, medicines, and other related products. Asymchem Laboratories serves customers worldwide.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
WuXi XDC
•
06 Nov 2023 21:16
WuXi XDC IPO: Valuation First-Look
WuXi XDC is pre-marketing an HKEx IPO to raise US$500m. In this note, we present our forecasts and take the first look at the potential valuation...
Arun George
Follow
733 Views
Share
bullish
•
Midea Group Co Ltd A
•
02 Nov 2023 09:48
Past A/H Listings Performance - Have Been a Mixed Bag
Two of the biggest deals in the Hong Kong pipeline are A/H listings for S.F. Holding (002352 CH) and Midea Group (000333 CH). In this note, we have...
Sumeet Singh
Follow
542 Views
Share
bearish
•
WuXi XDC
•
01 Nov 2023 18:21
WuXi XDC IPO: The Bear Case
The bear case rests on margins on a downward trend, large customer concentration, high related party transactions and volatile FCF generation.
Arun George
Follow
678 Views
Share
bullish
•
Midea Group Co Ltd A
•
01 Nov 2023 09:55
Midea A/H Listing - Filing Updates - Growth and Margins Pick Up
Midea Group Co Ltd A (000333 CH), one of the world’s largest home appliance producers, aims to raise up to US$3bn in its H-share listing.
Sumeet Singh
Follow
580 Views
Share
bearish
•
Quantitative Analysis
•
29 Oct 2023 10:10
A-H Premium Weekly (Oct 27th): Beigene, CMS, Guangzhou Auto, China Longyuan
We analyzed A-H premium changes in the past week and highlight A-H premium changes for Beigene, China Merchants Securities, Guangzhou Auto, China...
Ke Yan, CFA, FRM
Follow
564 Views
Share
First
Previous
7
8
9
10
11
12
13
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.5
x